{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T09:05:17Z","timestamp":1779354317787,"version":"3.51.4"},"reference-count":28,"publisher":"e-Century Publishing Corporation","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/xcie5727","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T03:53:17Z","timestamp":1777348397000},"page":"2919-2934","source":"Crossref","is-referenced-by-count":0,"title":["Identification of chemotherapy-related risk factors for lymphedema in breast cancer patients using Lasso regression and model development"],"prefix":"10.62347","volume":"18","author":[{"given":"Yanxiang","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"48694","published-online":{"date-parts":[[2026]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A and Bray F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71: 209-249.","journal-title":"CA Cancer J Clin"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10549-023-06947-7","article-title":"Advances in the prevention and treatment of breast cancer-related lymphedema","volume":"200","author":"Donahue","year":"2023","unstructured":"Donahue PMC, MacKenzie A, Filipovic A and Koelmeyer L. Advances in the prevention and treatment of breast cancer-related lymphedema. Breast Cancer Res Treat 2023; 200: 1-14.","journal-title":"Breast Cancer Res Treat"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/S1470-2045(13)70076-7","article-title":"Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis","volume":"14","author":"DiSipio","year":"2013","unstructured":"DiSipio T, Rye S, Newman B and Hayes S. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol 2013; 14: 500-515.","journal-title":"Lancet Oncol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial","volume":"15","author":"Donker","year":"2014","unstructured":"Donker M, van Tienhoven G, Straver ME, Meijnen P, van de Velde CJ, Mansel RE, Cataliotti L, Westenberg AH, Klinkenbijl JH, Orzalesi L, Bouma WH, van der Mijle HC, Nieuwenhuijzen GA, Veltkamp SC, Slaets L, Duez NJ, de Graaf PW, van Dalen T, Marinelli A, Rijna H, Snoj M, Bundred NJ, Merkus JW, Belkacemi Y, Petignat P, Schinagl DA, Coens C, Messina CG, Bogaerts J and Rutgers EJ. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol 2014; 15: 1303-1310.","journal-title":"Lancet Oncol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1001\/jamasurg.2023.2414","article-title":"Feasibility and clinical utility of prediction models for breast cancer-related lymphedema incorporating racial differences in disease incidence","volume":"158","author":"Rochlin","year":"2023","unstructured":"Rochlin DH, Barrio AV, McLaughlin S, Van Zee KJ, Woods JF, Dayan JH, Coriddi MR, McGrath LA, Bloomfield EA, Boe L and Mehrara BJ. Feasibility and clinical utility of prediction models for breast cancer-related lymphedema incorporating racial differences in disease incidence. JAMA Surg 2023; 158: 954-964.","journal-title":"JAMA Surg"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"102124","DOI":"10.1016\/j.suronc.2024.102124","article-title":"Breast cancer-related lymphedema: a critical review on recent progress","volume":"56","author":"Sharifi","year":"2024","unstructured":"Sharifi N and Ahmad S. Breast cancer-related lymphedema: a critical review on recent progress. Surg Oncol 2024; 56: 102124.","journal-title":"Surg Oncol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1093\/postmj\/qgae181","article-title":"The 2024 revision of the declaration of Helsinki: a modern ethical framework for medical research","volume":"101","author":"Wen","year":"2025","unstructured":"Wen B, Zhang G, Zhan C, Chen C and Yi H. The 2024 revision of the declaration of Helsinki: a modern ethical framework for medical research. Postgrad Med J 2025; 101: 371-382.","journal-title":"Postgrad Med J"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Kuruvilla AS, Krajewski A, Li X, Yang J, Mulay SR, Agha SM, Kohli HK, Bellis RM, Tannous HJ and Shroyer ALW. Risk factors associated with postmastectomy breast cancer lymphedema: a multicenter retrospective analysis. Ann Plast Surg 2022; 88 Suppl 3: S239-S245.","DOI":"10.1097\/SAP.0000000000003107"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00066-025-02482-0","article-title":"Breast cancer related lymphedema and shoulder mobility following radiotherapy","volume":"202","author":"Jarm","year":"2026","unstructured":"Jarm T, Besic N, Arnez RC, But-Hadzic J and Ratosa I. Breast cancer related lymphedema and shoulder mobility following radiotherapy. Strahlenther Onkol 2026; 202: 187-195.","journal-title":"Strahlenther Onkol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1007\/s12282-020-01088-x","article-title":"Risk factors for breast cancer-related lymphedema: correlation with docetaxel administration","volume":"27","author":"Aoishi","year":"2020","unstructured":"Aoishi Y, Oura S, Nishiguchi H, Hirai Y, Miyasaka M, Kawaji M, Shima A and Nishimura Y. Risk factors for breast cancer-related lymphedema: correlation with docetaxel administration. Breast Cancer 2020; 27: 929-937.","journal-title":"Breast Cancer"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1001\/jamaoncol.2022.1628","article-title":"Risk factors and racial and ethnic disparities in patients with breast cancer-related lymphedema","volume":"8","author":"Montagna","year":"2022","unstructured":"Montagna G, Zhang J, Sevilimedu V, Charyn J, Abbate K, Gomez EA, Mehrara B, Morrow M and Barrio AV. Risk factors and racial and ethnic disparities in patients with breast cancer-related lymphedema. JAMA Oncol 2022; 8: 1195-1200.","journal-title":"JAMA Oncol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.ijrobp.2013.02.018","article-title":"A model to estimate the risk of breast cancer-related lymphedema: combinations of treatment-related factors of the number of dissected axillary nodes, adjuvant chemotherapy, and radiation therapy","volume":"86","author":"Kim","year":"2013","unstructured":"Kim M, Kim SW, Lee SU, Lee NK, Jung SY, Kim TH, Lee ES, Kang HS and Shin KH. A model to estimate the risk of breast cancer-related lymphedema: combinations of treatment-related factors of the number of dissected axillary nodes, adjuvant chemotherapy, and radiation therapy. Int J Radiat Oncol Biol Phys 2013; 86: 498-503.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.21037\/gs-24-252","article-title":"Predictive modeling of breast cancer-related lymphedema using machine learning algorithms","volume":"13","author":"Sun","year":"2024","unstructured":"Sun Y, Xia X and Liu X. Predictive modeling of breast cancer-related lymphedema using machine learning algorithms. Gland Surg 2024; 13: 2243-2252.","journal-title":"Gland Surg"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1334082","DOI":"10.3389\/fonc.2024.1334082","article-title":"Comparison of machine learning models to predict the risk of breast cancer-related lymphedema among breast cancer survivors: a cross-sectional study in China","volume":"14","author":"Du","year":"2024","unstructured":"Du J, Yang J, Yang Q, Zhang X, Yuan L and Fu B. Comparison of machine learning models to predict the risk of breast cancer-related lymphedema among breast cancer survivors: a cross-sectional study in China. Front Oncol 2024; 14: 1334082.","journal-title":"Front Oncol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"15602","DOI":"10.1038\/s41598-024-66573-1","article-title":"Development and validation of a nomogram for breast cancer-related lymphedema","volume":"14","author":"Jiang","year":"2024","unstructured":"Jiang Q, Hu H, Liao J, Li ZH and Tan J. Development and validation of a nomogram for breast cancer-related lymphedema. Sci Rep 2024; 14: 15602.","journal-title":"Sci Rep"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"80","DOI":"10.47102\/annals-acadmedsg.2023264","article-title":"Defining breast cancer-related lymphedema (BCRL) prevalence and risk factors: a pragmatic approach to lymphedema surveillance","volume":"53","author":"Hing","year":"2024","unstructured":"Hing JX, Chua YN, Tan PT, Tan MSL, Mok CW, Seet MYL, Lin ZC, Seah CM, Lee WP and Tan SM. Defining breast cancer-related lymphedema (BCRL) prevalence and risk factors: a pragmatic approach to lymphedema surveillance. Ann Acad Med Singap 2024; 53: 80-89.","journal-title":"Ann Acad Med Singap"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1245\/s10434-012-2290-x","article-title":"Nomograms for predicting the risk of arm lymphedema after axillary dissection in breast cancer","volume":"19","author":"Bevilacqua","year":"2012","unstructured":"Bevilacqua JL, Kattan MW, Changhong Y, Koifman S, Mattos IE, Koifman RJ and Bergmann A. Nomograms for predicting the risk of arm lymphedema after axillary dissection in breast cancer. Ann Surg Oncol 2012; 19: 2580-2589.","journal-title":"Ann Surg Oncol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1111\/jan.15005","article-title":"Breast cancer-related lymphoedema: risk factors and prediction model","volume":"78","author":"Mart&#xED","year":"2022","unstructured":"Martínez-Jaimez P, Armora Verdú M, Forero CG, Álvarez Salazar S, Fuster Linares P, Monforte-Royo C and Masia J. Breast cancer-related lymphoedema: risk factors and prediction model. J Adv Nurs 2022; 78: 765-775.","journal-title":"J Adv Nurs"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1186\/s12885-023-10814-5","article-title":"Risk factors for the development of severe breast cancer-related lymphedema: a retrospective cohort study","volume":"23","author":"Liu","year":"2023","unstructured":"Liu X, Sun K, Yang H, Xia L, Lu K, Meng X and Li Y. Risk factors for the development of severe breast cancer-related lymphedema: a retrospective cohort study. BMC Cancer 2023; 23: 361.","journal-title":"BMC Cancer"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13014-025-02663-2","article-title":"Risk factors for severity of breast cancer-related lymphedema","volume":"20","author":"Bahanesteh","year":"2025","unstructured":"Bahanesteh A, Yarmohammadi H, Shahshenas S, Dalil D, Soltanipur M, Taheri H and Sheikhi Z. Risk factors for severity of breast cancer-related lymphedema. Radiat Oncol 2025; 20: 81.","journal-title":"Radiat Oncol"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Lin C, Su J, Wu AJ, Lin N, Hossack MS, Shi W, Xu W, Liu FF and Kwan JYY. External validation of a 5-factor risk model for breast cancer-related lymphedema. JAMA Netw Open 2025; 8: e2455383.","DOI":"10.1001\/jamanetworkopen.2024.55383"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Shen A, Ye J, Zhao H, Qiang W, Zhao H, Huang Y, Zhou Y, Wang Y, Li X, Zhang Z, Bian J, Zhang L, Wu P, Wang Y and Lu Q. Risk factors and prediction model of breast cancer-related lymphoedema in a Chinese cancer centre: a prospective cohort study protocol. BMJ Open 2024; 14: e089769.","DOI":"10.1136\/bmjopen-2024-089769"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"102023","DOI":"10.1016\/j.ejon.2021.102023","article-title":"Developing and validating a prediction model for lymphedema detection in breast cancer survivors","volume":"54","author":"Wei","year":"2021","unstructured":"Wei X, Lu Q, Jin S, Li F, Zhao Q, Cui Y, Jin S, Cao Y and Fu MR. Developing and validating a prediction model for lymphedema detection in breast cancer survivors. Eur J Oncol Nurs 2021; 54: 102023.","journal-title":"Eur J Oncol Nurs"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"102258","DOI":"10.1016\/j.ejon.2022.102258","article-title":"Development and validation of a risk prediction model for breast cancer-related lymphedema in postoperative patients with breast cancer","volume":"63","author":"MM","year":"2023","unstructured":"Li MM, Wu PP, Qiang WM, Li JQ, Zhu MY, Yang XL and Wang Y. Development and validation of a risk prediction model for breast cancer-related lymphedema in postoperative patients with breast cancer. Eur J Oncol Nurs 2023; 63: 102258.","journal-title":"Eur J Oncol Nurs"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"3518","DOI":"10.1097\/JS9.0000000000001278","article-title":"Incidence and risk factors of breast cancer-related lymphedema in Korea: a nationwide retrospective cohort study","volume":"110","author":"Ahn","year":"2024","unstructured":"Ahn HR, Jeong HE, Jeong C, Kang SY, Jung SH, Youn HJ and Kim JS. Incidence and risk factors of breast cancer-related lymphedema in Korea: a nationwide retrospective cohort study. Int J Surg 2024; 110: 3518-3526.","journal-title":"Int J Surg"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1002\/jso.27841","article-title":"Breast cancer-related lymphedema: a comprehensive analysis of risk factors","volume":"130","author":"Siotos","year":"2024","unstructured":"Siotos C, Arnold SH, Seu M, Lunt L, Ferraro J, Najafali D, Damoulakis G, Vorstenbosch J, Mehrara BJ, Antony AK, Shenaq DS and Kokosis G. Breast cancer-related lymphedema: a comprehensive analysis of risk factors. J Surg Oncol 2024; 130: 1521-1531.","journal-title":"J Surg Oncol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"102326","DOI":"10.1016\/j.ejon.2023.102326","article-title":"Risk prediction models for breast cancer-related lymphedema: a systematic review and meta-analysis","volume":"64","author":"Shen","year":"2023","unstructured":"Shen A, Wei X, Zhu F, Sun M, Ke S, Qiang W and Lu Q. Risk prediction models for breast cancer-related lymphedema: a systematic review and meta-analysis. Eur J Oncol Nurs 2023; 64: 102326.","journal-title":"Eur J Oncol Nurs"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s13643-022-02084-2","article-title":"Prediction models for breast cancer-related lymphedema: a systematic review and critical appraisal","volume":"11","author":"Lin","year":"2022","unstructured":"Lin Q, Yang T, Yongmei J and Die YM. Prediction models for breast cancer-related lymphedema: a systematic review and critical appraisal. Syst Rev 2022; 11: 217.","journal-title":"Syst Rev"}],"container-title":["American Journal of Translational Research"],"original-title":[],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T08:08:18Z","timestamp":1779350898000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/18\/4\/ajtr0170312.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":28,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.62347\/xcie5727","relation":{},"ISSN":["1943-8141"],"issn-type":[{"value":"1943-8141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]}}}